The Clinical and Financial Burden of Pressure Injuries
In support of World Wide Pressure Injury Prevention Day on November 18, Rehabtronics is pleased to release our whitepaper on the clinical and financial burden of pressure injuries. Millions of…
Articles & Webinars
November 18 is Pressure Injury Prevention Day
Organizations across the world have been observing World Wide Pressure Injury Prevention Day on the third Thursday of the month since 2013. This year’s awareness programs will be held on…
FDA Clears Prelivia, a Medical Device that Protects Patients from Pressure Injuries at Hospitals and Care Homes
VANCOUVER, BC, Sept. 1, 2021 /PRNewswire/ — The U.S. Food and Drug Administration has provided 510 (k) Clearance for Prelivia, a neurostimulation device developed by Rehabtronics that promotes healthy blood circulation and…
Prelivia Receives FDA Clearance
The U.S. Food and Drug Administration has provided 510 (k) Clearance for Prelivia, a neurostimulation device that promotes healthy blood circulation and maintains healthy tissue in people who are bedridden or chair bound. Annually, more than 2.5 million people in the United States suffer from pressure injuries, also known as bed sores, and up to 60,000 people die.
CABHI’s MC2 Program Accelerates Rehabtronics’ Path to Market
The Centre for Aging + Brain Health Innovation (CABHI) awarded access to its Mentorship, Capital and Continuation (MC2) program to Rehabtronics in January. The program helps companies unlock funding to accelerate business growth by providing access to leading investors, buyers, industry leaders and advisory from Silicon Valley.